MK-3577

CAS No. 1019112-29-8

MK-3577( MK 3577 | MK3577 )

Catalog No. M10091 CAS No. 1019112-29-8

A potent, oral active glucagon receptor antagonist blocking the glucagon effect for the treatment of T2DM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 1143 Get Quote
50MG 2322 Get Quote
100MG 3060 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    MK-3577
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent, oral active glucagon receptor antagonist blocking the glucagon effect for the treatment of T2DM.
  • Description
    A potent, oral active glucagon receptor antagonist blocking the glucagon effect for the treatment of T2DM; inhibits glucagon-mediated cAMP increases in CHO cells expressing the human glucagon receptor with IC50 of 8.3 nM.Diabetes Phase 2 Discontinued.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    MK 3577 | MK3577
  • Pathway
    GPCR/G Protein
  • Target
    Glucagon Receptor
  • Recptor
    Glucagon Receptor
  • Research Area
    Metabolic Disease
  • Indication
    Diabetes

Chemical Information

  • CAS Number
    1019112-29-8
  • Formula Weight
    521.03
  • Molecular Formula
    C30H30ClFN2O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CCCC(C1=CC=C(C=C1)C(=O)NCCC(=O)O)C(C2=CC=C(C=C2)Cl)C3=CNC4=C3C=C(C=C4F)C
  • Chemical Name
    3-(4-((1R,2S)-1-(4-chlorophenyl)-1-(7-fluoro-5-methyl-1H-indol-3-yl)pentan-2-yl)benzamido)propanoic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Peng JZ, et al. AAPS J. 2014 Nov;16(6):1259-70.
molnova catalog
related products
  • Semaglutide

    Semaglutide has two amino acid substitutions compared to human GLP-1 (Aib8, Arg34) and is derivatized at lysine 26.

  • CCG-143140

    CCG-143140 is a GLP-1 receptor inverse agonists.

  • MK-0893

    A potent, selective, reversible and competitive antagonist of glucagon receptor with high binding affinity (IC(=50=6.6 nM) and functional cAMP activity (IC50=15.7 nM).